Guardion Health Sciences, Inc.
GHSIDelisted Oct 11, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001642375
Guardion Health Sciences, Inc. was delisted on Oct 11, 2024; its insiders filed their last Form 4 on Aug 28, 2024; 15 institutions reported holding it in 13F filings for Q3 2024, worth $587.7K in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Guardion Health Sciences, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +1 vs. Q2 2022
- Shares held
- 4.78M
- +263.9K (+5.8%) vs. Q2 2022
- Total value
- $659.0K
- +$4.72K (+0.7%) vs. Q2 2022
- New holders
- 3
- 7 more added
- Sold out
- 2
- 5 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GHSI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 15 | $587.7K |
| Q2 2024 | 12 | $674.9K |
| Q1 2024 | 12 | $595.0K |
| Q4 2023 | 11 | $347.9K |
| Q3 2023 | 14 | $497.7K |
| Q2 2023 | 13 | $387.4K |
| Q1 2023 | 10 | $314.5K |
| Q4 2022 | 22 | $545.8K |
| Q3 2022 | 23 | $659.0K |
| Q2 2022 | 22 | $654.3K |
| Q1 2022 | 20 | $1.09M |
| Q4 2021 | 20 | $1.61M |
| Q3 2021 | 19 | $3.82M |
| Q2 2021 | 16 | $4.80M |
| Q1 2021 | 14 | $4.14M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Guardion Health Sciences, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 409 | $0 | 0.00% | −2−0.5% | Reduced |
| Signaturefd, LLC | 996 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 300 | $0 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 834 | $115 | 0.00% | 00.0% | Unchanged |
| StoneX Group Inc. | 13,705 | $1.89K | 0.00% | −1,295−8.6% | Reduced |
| Raymond James Financial Services Advisors, Inc. | 15,000 | $2.00K | 0.00% | +15,000 | New |
| Citigroup Inc | 18,617 | $3.00K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 18,926 | $3.00K | 0.00% | +156+0.8% | Added |
| Goldman Sachs Group Inc | 25,164 | $3.00K | 0.00% | +12,611+100.5% | Added |
| Tower Research Capital LLC (TRC) | 38,574 | $5.00K | 0.00% | −34,628−47.3% | Reduced |
| Balyasny Asset Management LLC | 44,856 | $6.00K | 0.00% | +44,856 | New |
| Northern Trust Corp | 57,649 | $8.00K | 0.00% | +32,852+132.5% | Added |
| Virtu Financial LLC | 79,277 | $11.0K | 0.00% | −38,717−32.8% | Reduced |
| State Street Corp | 134,934 | $19.0K | 0.00% | 00.0% | Unchanged |
| Ergoteles LLC | 137,705 | $19.0K | 0.00% | +137,705 | New |
| UBS Group AG | 152,596 | $21.0K | 0.00% | +74,679+95.8% | Added |
| Geode Capital Management, LLC | 169,865 | $23.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 250,000 | $35.0K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 288,281 | $39.0K | 0.00% | −787,758−73.2% | Reduced |
| Susquehanna International Group, LLP | 292,640 | $40.0K | 0.00% | +272,682+1,366.3% | Added |
| BlackRock Inc. | 501,454 | $69.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 816,897 | $113.0K | 0.00% | +451,114+123.3% | Added |
| Renaissance Technologies LLC | 1,723,950 | $238.0K | 0.00% | +149,200+9.5% | Added |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −34,636−100.0% | Sold out |
| JustInvest LLC | 0 | $0 | 0.00% | −29,940−100.0% | Sold out |